Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HouseH.R. 10763119th Congress

Know Your Risk Act

← Back to bill overviewView on Congress.gov →

Full Text

Official text as published. Use Ctrl+F / Cmd+F to search within the document.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10763 Introduced in House (IH)]

<DOC>

119th CONGRESS
  2d Session
                               H. R. 10763

   To direct the Secretary of Health and Human Services to submit to 
Congress a report on breast cancer risk assessment tools, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 6, 2026

  Ms. Letlow introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
   To direct the Secretary of Health and Human Services to submit to 
Congress a report on breast cancer risk assessment tools, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Know Your Risk Act''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) In 2026, approximately 382,640 women in the United 
        States will be diagnosed with breast cancer.
            (2) Early detection of breast cancer is associated with 
        improved survival rates, including a 5-year relative survival 
        rate of approximately 99 percent for cancers detected at a 
        localized stage.
            (3) In the United States alone, women have a 1-in-8 
        lifetime risk of being diagnosed with breast cancer.
            (4) Approximately 85 percent of individuals diagnosed with 
        breast cancer have no family history of the disease.
            (5) The risk that an individual will develop breast cancer 
        is influenced by factors including age, race, ethnicity, 
        genetic mutations, reproductive history, breast density, family 
        history, and exposures to certain drugs.
            (6) Most risk factors for breast cancer do not directly 
        cause cancer but do increase the chance of DNA damage in cells 
        that may lead to breast cancer.
            (7) Breast cancer risk assessment tools support health care 
        providers in estimating the risk that a woman will develop 
        breast cancer and informing appropriate screening, detection, 
        treatment, and prevention strategies.
            (8) Multiple breast cancer risk assessment tools exist, 
        including the National Cancer Institute's Gail Model and the 
        Tyrer-Cuzick Risk Assessment Calculator.
            (9) Despite the availability of such tools, there is no 
        single, centralized, or widely recognized breast cancer risk 
        assessment tool for patients, providers, and health systems.
            (10) Strengthening education and awareness of breast cancer 
        risks and of tools that assess such risks can alleviate 
        disparities in early detection and treatment across geographic 
        regions, age groups, and health care settings.
            (11) In 2025, the Food and Drug Administration granted De 
        Novo authorization to the first artificial intelligence-based 
        mammogram risk assessment tool to predict breast cancer risk, 
        further expanding the range of available tools but also 
        increasing the need for improved coordination and evaluation of 
        methodologies to reach a broader range of women.
            (12) Increasing Federal investments in breast cancer 
        research and strengthening public-private partnerships is 
        essential to streamline the current patchwork of breast cancer 
        risk assessment tools to improve consistency and access while 
        enabling earlier and more accurate detection for women 
        nationwide.

SEC. 3. REPORT ON BREAST CANCER RISK ASSESSMENT TOOLS.

    (a) In General.--Not later than 180 days after the date of 
enactment of this Act, the Secretary of Health and Human Services shall 
submit to Congress a report that includes--
            (1) identification of inaccuracies resulting from the use 
        of existing breast cancer risk assessment tools;
            (2) gaps in use of existing breast cancer risk assessment 
        tools among different populations; and
            (3) factors that contribute to such inaccuracies and gaps 
        in use.
    (b) Development of Comprehensive Breast Cancer Risk Assessment 
Tool.--The report under subsection (a) shall include--
            (1) an outline of the planning needed to create a single 
        breast cancer risk assessment tool that is comprehensive and 
        publicly accessible;
            (2) strategies to provide for public awareness of such a 
        breast cancer risk assessment tool; and
            (3) recommendations on how to build consensus on the 
        development of such a breast cancer risk assessment tool 
        among--
                    (A) patients;
                    (B) medical providers;
                    (C) institutions of higher education;
                    (D) for-profit and nonprofit entities;
                    (E) health care entities (as defined in section 
                60.3 of title 45, Code of Federal Regulations (or any 
                successor regulation)); and
                    (F) other entities, as the Secretary determines 
                relevant.

SEC. 4. BREAST CANCER RISK ASSESSMENT REQUIREMENT IN GRANT PROGRAMS.

    (a) Breast Cancer Risk Assessment Requirement.--
            (1) Grant requirements.--Section 1501(a) of the Public 
        Health Service Act (42 U.S.C. 300k) is amended--
                    (A) in paragraph (1), by inserting ``conduct 
                evidence-based breast cancer risk assessments and to'' 
                before ``screen women'';
                    (B) in paragraph (4), by inserting ``, including 
                training on and clinical application of validated 
                breast cancer risk assessment models'' before the 
                semicolon at the end;
                    (C) in paragraph (5), by striking ``; and'' and 
                inserting a semicolon;
                    (D) by redesignating paragraph (6) as paragraph 
                (9);
                    (E) by inserting after paragraph (5) the following:
            ``(6) to implement standardized, evidence-based breast 
        cancer risk assessment tools in appropriate clinical settings, 
        including through integration into electronic health record 
        systems;
            ``(7) to develop and disseminate public information and 
        education programs regarding breast cancer risk factors, 
        individualized risk assessment, genetic predisposition, and 
        available risk-reduction strategies;
            ``(8) to support research, validation, and improvement of 
        existing breast cancer risk assessment models to improve 
        accuracy across racial, ethnic, geographic, and age 
        populations; and''; and
                    (F) in paragraph (9), as redesignated, by striking 
                ``(5)'' and inserting ``(8)''.
            (2) Conforming amendments.--Section 1503 of the Public 
        Health Service Act (42 U.S.C. 300mm) is amended--
                    (A) in subsection (a)(4), by striking ``(6)'' and 
                inserting ``(9)''; and
                    (B) in subsection (d)(3)(B)(ii), by striking 
                ``(6)'' and inserting ``(9)''.
    (b) Risk Assessment Reporting.--Section 1504(i) of the Public 
Health Service Act (42 U.S.C. 300n) is amended to read as follows:
    ``(i) Reports to Secretary.--
            ``(1) Required reports.--The Secretary may not make a grant 
        under section 1501 unless the State involved agrees to submit 
        to the Secretary the report required under paragraph (2) and 
        such other reports as the Secretary may require with respect to 
        the grant.
            ``(2) Risk assessment reporting.--A State receiving a grant 
        under section 1501 shall submit to the Secretary, at such time 
        and in such manner as the Secretary may require, information 
        on--
                    ``(A) the number of individuals receiving breast 
                cancer risk assessments under the programs of the State 
                funded through such grant;
                    ``(B) the number and percentage of individuals 
                receiving breast cancer risk assessments under such 
                programs identified as being at elevated risk;
                    ``(C) the number of referrals made for enhanced 
                screening, genetic counseling, preventive therapy, or 
                other breast cancer risk-reduction services through 
                such programs; and
                    ``(D) disparities in access to breast cancer risk 
                assessments and follow-up services among geographic 
                regions, medically underserved populations, and other 
                populations, as determined relevant by the 
                Secretary.''.
                                 <all>